Pediatric Endocrinology, Diabetes and Metabolism最新文献

{"title":"The role of the novel adipokines vaspin and omentin in chronic inflammatory diseases.","authors":"Joanna Radzik-Zając,&nbsp;Krzysztof Wytrychowski,&nbsp;Andrzej Wiśniewski,&nbsp;Wojciech Barg","doi":"10.5114/pedm.2022.121371","DOIUrl":"https://doi.org/10.5114/pedm.2022.121371","url":null,"abstract":"<p><p>Obesity is a disease of epidemic proportions in many countries around the world. White adipose tissue is an active endocrine organ; therefore, its excess results in chronic and systemic inflammation. This inflammation is caused and maintained mostly by adipokines secreted by adipose tissue cells, mainly adipocytes and macrophages. The relatively newly discovered adipokines comprise vaspin and omentin. Their concentration in the blood, tissues, or bronchial secretion varies depending on the amount of adipose tissue and other accompanying factors, including comorbidities. The aim of this article is to demonstrate the usefulness of omentin and vaspin as biomarkers in inflammatory diseases. The Medline/PubMed database was used to search for information on obesity, inflammation, omentin, vaspin, and adipose tissue. Data from selected scientific studies, both original and review papers, are presented. Vaspin has been found to improve insulin sensitivity mainly in white adipose tissue. Omentin has an anti-inflammatory effect and, like vaspin, sensitizes tissues to insulin. The serum concentration and tissue expression of both adipokines are different in different inflammatory diseases. This review aims to present the biological functions of vaspin and omentin in the body and to indicate the possible use of these adipokines as disease markers in the future.</p>","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"29 1","pages":"48-52"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/05/3c/PEDM-29-48233.PMC10226453.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9575317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"\"The obesity pandemic\" in the COVID-19 pandemic - new treatment for an old problem.","authors":"Kalina Fabin-Czepiel,&nbsp;Karolina Pieczyńska-Chapuła,&nbsp;Grażyna Deja","doi":"10.5114/pedm.2023.129342","DOIUrl":"https://doi.org/10.5114/pedm.2023.129342","url":null,"abstract":"<p><p>Obesity is a worldwide problem, and the fact that it increasingly affects children and adolescents is worrying. The COVID-19 pandemic and the restrictions introduced affected the physical activity of children and adolescents, and changed their lifestyle and the amount of time spent in front of screens, which are significant factors correlated with weight gain. Due to the scale of the problem of obesity and overweight, much attention is currently paid to seeking effective forms of therapy in these different, difficult circumstances. Interventions promoting a healthy lifestyle among obese children after the COVID-19 pandemic are particularly important and necessary. This article provides a review of the literature on the recent worsening of obesity in the paediatric population, with particular emphasis on the importance of the COVID-19 pandemic. New methods of fighting obesity with the use of telemedicine and current methods of pharmacotherapy, including new drugs, are presented.</p>","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"29 2","pages":"104-111"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fb/bd/PEDM-29-51055.PMC10411083.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41137220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lipid metabolism and renal function markers in obese adolescents.","authors":"Aleksandra Radosz,&nbsp;Anna Obuchowicz","doi":"10.5114/pedm.2023.125612","DOIUrl":"https://doi.org/10.5114/pedm.2023.125612","url":null,"abstract":"<p><strong>Aim of the study: </strong>To investigate the relationship of renal function markers and lipid metabolism parameters in obese adolescents.</p><p><strong>Material and methods: </strong>The study comprised 76 children aged 11-17 years, hospitalised due to: obesity (group I - 19 children) or obesity accompanied by obesity-induced hypertension (group II - 30 children) or normosthenic children with a diagnosed tension headaches (control group - 27 children). A subgroup with metabolic syndrome (MS - 16 children) was also separated. Renal function was assessed on the basis of: serum creatinine concentration, glomerular filtration rate estimated using Schwartz eqation (eGFR), determination of plasma and urinary neutrophil gelatinase-associated lipocalin and cystatin C. On the basis of statistical analysis, it was checked whether renal function markers depend on lipid metabolism parameters.</p><p><strong>Results: </strong>In the study groups mean creatinine concentrations were significantly higher and eGFR values significantly lower than in the control group, but they remained within norm. Differences in plasma and urinary neutrophil gelatinase-associated lipocalin concentrations were not significant. Mean cystatin C concentrations were significantly higher in the group of obese children. Multiple linear regression analysis showed that the most important predictor was: LDL-C for urinary neutrophil gelatinase-associated lipocalin (R2 = 0.42) and TG for eGFR (R2 = 0.44) concentrations in group I; cholesterol for creatinine concentrations in MS group (R2 = 0.44).</p><p><strong>Conclusions: </strong>Renal function of the obese adolescents included in the study was normal and the associations with lipid metabolism were poorly expressed.</p>","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"29 2","pages":"91-96"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bd/7d/PEDM-29-50266.PMC10411080.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41158503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The incidence of insulin resistance based on indices calculated using the HOMA and Belfiore methods and its impact on the occurrence of metabolic complications in prepubertal children born small for gestational age","authors":"Anna Łupińska, Renata Stawerska, Małgorzata Szałapska, Marzena Kolasa-Kicińska, Krzysztof Jeziorny, Wojciech Stawerski, Sara Aszkiełowicz, Andrzej Lewiński","doi":"10.5114/pedm.2023.130027","DOIUrl":"https://doi.org/10.5114/pedm.2023.130027","url":null,"abstract":"AMA Łupińska A, Stawerska R, Szałapska M, et al. The incidence of insulin resistance based on indices calculated using the HOMA and Belfiore methods and its impact on the occurrence of metabolic complications in prepubertal children born small for gestational age. Pediatric Endocrinology Diabetes and Metabolism. 2023;29(3):175-183. doi:10.5114/pedm.2023.130027. APA Łupińska, A., Stawerska, R., Szałapska, M., Kolasa-Kicińska, M., Jeziorny, K., & Stawerski, W. et al. (2023). The incidence of insulin resistance based on indices calculated using the HOMA and Belfiore methods and its impact on the occurrence of metabolic complications in prepubertal children born small for gestational age. Pediatric Endocrinology Diabetes and Metabolism, 29(3), 175-183. https://doi.org/10.5114/pedm.2023.130027 Chicago Łupińska, Anna, Renata Stawerska, Małgorzata Szałapska, Marzena Kolasa-Kicińska, Krzysztof Jeziorny, Wojciech Stawerski, and Sara Aszkiełowicz et al. 2023. \"The incidence of insulin resistance based on indices calculated using the HOMA and Belfiore methods and its impact on the occurrence of metabolic complications in prepubertal children born small for gestational age\". Pediatric Endocrinology Diabetes and Metabolism 29 (3): 175-183. doi:10.5114/pedm.2023.130027. Harvard Łupińska, A., Stawerska, R., Szałapska, M., Kolasa-Kicińska, M., Jeziorny, K., Stawerski, W., Aszkiełowicz, S., and Lewiński, A. (2023). The incidence of insulin resistance based on indices calculated using the HOMA and Belfiore methods and its impact on the occurrence of metabolic complications in prepubertal children born small for gestational age. Pediatric Endocrinology Diabetes and Metabolism, 29(3), pp.175-183. https://doi.org/10.5114/pedm.2023.130027 MLA Łupińska, Anna et al. \"The incidence of insulin resistance based on indices calculated using the HOMA and Belfiore methods and its impact on the occurrence of metabolic complications in prepubertal children born small for gestational age.\" Pediatric Endocrinology Diabetes and Metabolism, vol. 29, no. 3, 2023, pp. 175-183. doi:10.5114/pedm.2023.130027. Vancouver Łupińska A, Stawerska R, Szałapska M, Kolasa-Kicińska M, Jeziorny K, Stawerski W et al. The incidence of insulin resistance based on indices calculated using the HOMA and Belfiore methods and its impact on the occurrence of metabolic complications in prepubertal children born small for gestational age. Pediatric Endocrinology Diabetes and Metabolism. 2023;29(3):175-183. doi:10.5114/pedm.2023.130027.","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135662032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lower percentages of natural killer cells in children with type 1 diabetes and their siblings.","authors":"Joanna Sieniawska, Aleksandra Krzewska, Anna Skowronek, Wiktoria Wrobel, Zaklina Tomczyk, Emilia Pach, Iga Rosolowska, Barbara Wilczynska, Iwona Beń-Skowronek","doi":"10.5114/pedm.2023.132029","DOIUrl":"10.5114/pedm.2023.132029","url":null,"abstract":"<p><strong>Introduction: </strong>One of the most common children's endocrine and autoimmune diseases in the world is type 1 diabetes mellitus (T1DM). The incidence of type 1 diabetes is constantly increasing, and according to current estimates, the number of children with T1DM in the world has exceeded 542,000. There are 3 main components emphasized in the pathogenesis: genetic and environmental factors, and the patient's immune system. Many publications have confirmed the role of natural killer cells (NK) in the pathogenesis of type 1 diabetes and other autoimmune diseases.</p><p><strong>Aim: </strong>The aim of the study was to evaluate the population of NK cells and pancreatic β cell autoantibodies in a group of children with T1DM and their healthy siblings in comparison with children from families with no history of autoimmune diseases.</p><p><strong>Material and methods: </strong>The research included 76 children with T1DM, 101 children from the sibling group, and 30 children from the control group. Peripheral blood was analysed on a FACSCalibur flow cytometer (Becton Dickinson) to evaluate the NK cell population. The results were presented as the percentage of NK cells among lymphocytes. Statistical analysis was performed using STATIS-TICA 10 PL software.</p><p><strong>Results: </strong>The mean percentage of NK cells in children with T1D (10.59 ±5.37) and in the sibling group (11.93 ±5.62) was statistically reduced in comparison to the control group (14.89 ±7.78) in sequence (Student's t -test: t = -3.24; df = 103; p = 0.002) (Stu-dent's t -test: t = -2.30; df = 128; p = 0.02). There was no statistically significant difference in the percentage of NK cells be-tween the group of children with T1DM and their siblings (Student's t -test: t = -1.59; df = 173; p = 0.11). In the group of sib-lings, the younger the child, the lower the reported percentage of NK cells. This relationship was statistically significant (test for the Pearson correlation coefficient t = 3.41; p = 0.0009; r = 0.33). In the group of children with type 1 diabetes, a similar relationship was not found. The concentration of anti-IA2 and anti-Znt8 antibodies was statistically significantly higher in the sibling group compared to the control group (anti-IA2 p = 0.0000001; anti-ZnT8 p = 0.00001), and the concentration of anti-GAD antibodies was comparable in both groups. In the group of children with type 1 diabetes, a positive correlation was demonstrated between the reduced percentage of NK cells and the coexistence of anti-GAD and anti-ZnT8 antibodies (Mann-Whitney U test Z = -2.02; p = 0.04). There was no similar relationship in the group of siblings.</p><p><strong>Conclusions: </strong>The reduced percentage of NK cells in children with T1DM and in their siblings compared to the control group suggests the role of NK cells in the pathogenesis of T1DM. Genetic predisposition and dysfunction of NK cells probably underlie the pathogenesis of T1DM.</p>","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"29 4","pages":"214-224"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10826694/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139571427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Premature pubarche during minipuberty - literature review and two case reports.","authors":"Anna Rakuś-Kwiatosz,&nbsp;Elżbieta Budzyńska,&nbsp;Iwona Beń-Skowronek","doi":"10.5114/pedm.2023.129343","DOIUrl":"https://doi.org/10.5114/pedm.2023.129343","url":null,"abstract":"<p><strong>Introduction: </strong>Isolated premature pubarche (PP) in infancy may be the reason for many diagnostic difficulties. This is due to the low incidence and, therefore, the limited number of studies on this subject and the lack of strict laboratory standards because of the physiological variability of gonadotropic hormone and androgen concentrations during minipuberty.</p><p><strong>Material and methods: </strong>We aimed to present current knowledge about PP in infancy based on the literature review and 2 cases of male infants with scrotal hair during minipuberty.</p><p><strong>Results: </strong>Isolated hair in the pubic region in a boy during the period of minipuberty requires differential diagnosis. After excluding serious aetiology, it seems to be a mild, self-limiting variant of precocious puberty. The phenomenon is probably a result of increased sensitivity of the hair follicles to transiently increased androgen concentration.</p><p><strong>Conclusions: </strong>Isolated pubic hair in infancy as a mild, self-limiting variant of precocious puberty in infants should be a diagnosis of exclusion. The condition resolves spontaneously, but it absolutely requires further follow-up to exclude serious aetiology in the case of puberty progression.</p>","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"29 2","pages":"112-117"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/41/57/PEDM-29-51056.PMC10411085.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41142870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Potential bacteriophages to overcome bacterial infection of Alcaligenes faecalis in diabetic ulcer.","authors":"Erlia Narulita,&nbsp;Vivi Indah Nur Cahyati,&nbsp;Riska A Febrianti,&nbsp;Mochammad Iqbal","doi":"10.5114/pedm.2023.125363","DOIUrl":"https://doi.org/10.5114/pedm.2023.125363","url":null,"abstract":"<p><strong>Introduction: </strong>Diabetes is a non-contagious disease, but it can cause various complications. One of the most common complications of diabetes is diabetic ulcers. Diabetic ulcers are infections that occur in the legs of diabetics due to the destruction of the deepest skin tissue. Recent studies have reported the presence of Alcaligenes faecalis with extensive drug resistance (XDR) properties as a cause of diabetic ulcers. Bacteriophages are known to have the ability to infect bacteria specifically so that they can be used as an alternative solution for treating diabetic ulcers. The purpose of this study was to determine the characteristics of bacteriophages capable of infecting Alcaligenes faecalis bacteria.</p><p><strong>Material and methods: </strong>The method used is the spot test method, host range, and identification of nucleic acid types.</p><p><strong>Results: </strong>The results showed that the 6 bacteriophages isolated, namely AFaV1, AFaV2, AFaV3, AFaV4, AFaV5, and AFaV6, had cloudy plaques with a diameter of ±3 mm. AFaV1, AFaV2, and AFaV4 isolates could infect all bacteria used; they were Klebsiella pneumoniae, Escherichia coli, and Staphylococcus aureus. Meanwhile, bacteriophage isolates AFaV3, AFaV5, and AFaV6 could infect Klebsiella pneumoniae and Staphylococcus aureus bacteria only. The nucleic acid types of the 6 bacteriophage samples were dsDNA with band length > 1 Kb.</p><p><strong>Conclusions: </strong>The 6 isolates that were isolated had the ability to infect by forming a prophage that could inhibit the growth of Alcaligenes faecalis and other pathogenic bacteria in diabetic ulcers.</p>","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"29 2","pages":"61-66"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/49/4c/PEDM-29-50192.PMC10411081.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41177207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Type 1 diabetes – What’s new in prevention and therapeutic strategies?","authors":"Aleksandra Pilśniak, Ewa Otto-Buczkowska","doi":"10.5114/pedm.2023.132028","DOIUrl":"https://doi.org/10.5114/pedm.2023.132028","url":null,"abstract":"AMA Pilśniak A, Otto-Buczkowska E. Type 1 diabetes – What’s new in prevention and therapeutic strategies?. Pediatric Endocrinology Diabetes and Metabolism. 2023;29(3):196-201. doi:10.5114/pedm.2023.132028. APA Pilśniak, A., & Otto-Buczkowska, E. (2023). Type 1 diabetes – What’s new in prevention and therapeutic strategies?. Pediatric Endocrinology Diabetes and Metabolism, 29(3), 196-201. https://doi.org/10.5114/pedm.2023.132028 Chicago Pilśniak, Aleksandra, and Ewa Otto-Buczkowska. 2023. \"Type 1 diabetes – What’s new in prevention and therapeutic strategies?\". Pediatric Endocrinology Diabetes and Metabolism 29 (3): 196-201. doi:10.5114/pedm.2023.132028. Harvard Pilśniak, A., and Otto-Buczkowska, E. (2023). Type 1 diabetes – What’s new in prevention and therapeutic strategies?. Pediatric Endocrinology Diabetes and Metabolism, 29(3), pp.196-201. https://doi.org/10.5114/pedm.2023.132028 MLA Pilśniak, Aleksandra et al. \"Type 1 diabetes – What’s new in prevention and therapeutic strategies?.\" Pediatric Endocrinology Diabetes and Metabolism, vol. 29, no. 3, 2023, pp. 196-201. doi:10.5114/pedm.2023.132028. Vancouver Pilśniak A, Otto-Buczkowska E. Type 1 diabetes – What’s new in prevention and therapeutic strategies?. Pediatric Endocrinology Diabetes and Metabolism. 2023;29(3):196-201. doi:10.5114/pedm.2023.132028.","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"43 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135667532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Type 1 diabetes mellitus prevention.","authors":"Lidia Groele, Agnieszka Szypowska","doi":"10.5114/pedm.2023.134130","DOIUrl":"10.5114/pedm.2023.134130","url":null,"abstract":"","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"29 4","pages":"209-213"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10826692/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139571466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparative analysis of obesity prevalence, antioxidant and oxidant status in children with Down syndrome – a sibling-controlled study","authors":"Marta Hetman, Ewa Barg, Sylwia Placzkowska","doi":"10.5114/pedm.2023.131513","DOIUrl":"https://doi.org/10.5114/pedm.2023.131513","url":null,"abstract":"AMA Hetman M, Barg E, Placzkowska S. Comparative analysis of obesity prevalence, antioxidant and oxidant status in children with Down syndrome – a sibling-controlled study. Pediatric Endocrinology Diabetes and Metabolism. 2023;29(3):134-142. doi:10.5114/pedm.2023.131513. APA Hetman, M., Barg, E., & Placzkowska, S. (2023). Comparative analysis of obesity prevalence, antioxidant and oxidant status in children with Down syndrome – a sibling-controlled study. Pediatric Endocrinology Diabetes and Metabolism, 29(3), 134-142. https://doi.org/10.5114/pedm.2023.131513 Chicago Hetman, Marta, Ewa Barg, and Sylwia Placzkowska. 2023. \"Comparative analysis of obesity prevalence, antioxidant and oxidant status in children with Down syndrome – a sibling-controlled study\". Pediatric Endocrinology Diabetes and Metabolism 29 (3): 134-142. doi:10.5114/pedm.2023.131513. Harvard Hetman, M., Barg, E., and Placzkowska, S. (2023). Comparative analysis of obesity prevalence, antioxidant and oxidant status in children with Down syndrome – a sibling-controlled study. Pediatric Endocrinology Diabetes and Metabolism, 29(3), pp.134-142. https://doi.org/10.5114/pedm.2023.131513 MLA Hetman, Marta et al. \"Comparative analysis of obesity prevalence, antioxidant and oxidant status in children with Down syndrome – a sibling-controlled study.\" Pediatric Endocrinology Diabetes and Metabolism, vol. 29, no. 3, 2023, pp. 134-142. doi:10.5114/pedm.2023.131513. Vancouver Hetman M, Barg E, Placzkowska S. Comparative analysis of obesity prevalence, antioxidant and oxidant status in children with Down syndrome – a sibling-controlled study. Pediatric Endocrinology Diabetes and Metabolism. 2023;29(3):134-142. doi:10.5114/pedm.2023.131513.","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135706356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}